iRhythm director exercises options, sells 5,312 shs
iRhythm Holdings, Inc. director Abhijit Y. Talwalkar reported option exercises and offsetting share sales under a pre-set trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
iRhythm Holdings, Inc. director Abhijit Y. Talwalkar reported option exercises and offsetting share sales under a pre-set trading plan. On May 11, 2026, he exercised 5,312 Employee Stock Options at $10.71 per share and acquired the same number of common shares.
That same day he sold an aggregate of 5,312 common shares in multiple open‑market transactions at prices ranging from about $115.61 to $120.53, resulting in no net change in his common stock holdings. After these transactions, he directly owned 20,299 common shares. All trades were executed pursuant to a Rule 10b5-1 trading plan established on May 12, 2025.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,312 shares ($570K approx. pre-tax spread)
Exercise and Sale
7 txns
Insider
TALWALKAR ABHIJIT Y
Role
Director
Bought
5,312 shs ($57K)
Sold
5,312 shs ($626K)
Approx. gross sale proceeds
$626K
Approx. exercise cost
$57K
Approx. pre-tax spread
$570K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 5,312 | $10.71 | $57K |
| Purchase | Common Stock | 5,312 | $10.71 | $57K |
| Sale | Common Stock | 940 | $116.0542 | $109K |
| Sale | Common Stock | 642 | $116.9812 | $75K |
| Sale | Common Stock | 2,293 | $118.0163 | $271K |
| Sale | Common Stock | 1,147 | $119.1557 | $137K |
| Sale | Common Stock | 290 | $120.53 | $35K |
Holdings After Transaction:
Employee Stock Option (right to buy) — 0 contracts (Direct);
Common Stock — 20,299 shares (Direct)
Footnotes (6)
- F1. All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.
- F2. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $115.61 to a high of $116.61, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.
- F3. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $116.62 to a high of $117.31, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.
- F4. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $117.68 to a high of $118.45, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.
- F5. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $118.70 to a high of $119.63, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.
- F6. The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.
Key Figures
Shares sold: 5,312 shares
Option exercise shares: 5,312 shares
Exercise price: $10.71 per share
+3 more
6 metrics
Shares sold
5,312 shares
Total common shares sold in open-market transactions on May 11, 2026
Option exercise shares
5,312 shares
Employee Stock Options exercised into common stock on May 11, 2026
Exercise price
$10.71 per share
Conversion or exercise price of Employee Stock Options
Post-transaction holdings
25,611 shares
Common stock directly owned after all May 11, 2026 trades
Highest reported sale price
$120.53 per share
Price for 290-share open-market sale of common stock
Sale price range (selected)
$115.61–$119.63
Ranges of actual sale prices across disclosed May 11, 2026 trades
Key Terms
Rule 10b5-1 trading plan, weighted-average sale price, Employee Stock Option (right to buy), expiration date
4 terms
Rule 10b5-1 trading plan regulatory
"All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average sale price financial
"Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026."
Employee Stock Option (right to buy) financial
"security_title": "Employee Stock Option (right to buy)""
expiration date financial
"This option has an expiration date of May 23, 2026."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did iRhythm (IRTC) director Abhijit Talwalkar report?
Abhijit Talwalkar reported exercising 5,312 stock options at $10.71 and selling 5,312 common shares in multiple open-market trades. The matched exercise and sale left his net common share count unchanged while converting option value into cash.
Were the iRhythm (IRTC) insider trades made under a Rule 10b5-1 plan?
Yes. All transactions were executed under a Rule 10b5-1 trading plan established by Abhijit Talwalkar on May 12, 2025. Such plans prearrange trading activity, which can indicate the timing of these sales was set in advance rather than being discretionary.
What options did the iRhythm (IRTC) director exercise in this Form 4 filing?
He exercised Employee Stock Options originally granted on May 23, 2016, covering 5,312 shares at a $10.71 exercise price. These options were part of a larger 21,248-share grant that vested monthly and carried an expiration date of May 23, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
